Bioequivalence of generic drugs.
Andrade C.
J Clin Psychiatry. 2015 Sep;76(9):e1130-1. doi: 10.4088/JCP.15f10300.
Hyperinflation-Definitions and Causes.
Saltiel M, Finnefrock M.
J Pharm Pract. 2018 Aug;31(4):370-373. doi: 10.1177/0897190018776392. Epub 2018 Jun 15.
Médicaments génériques et médicaments originaux.
Leclerc J, Blais C, Guénette L, Poirier P.
Perspect Infirm. 2016 Nov-Dec;13(5):39-46.
BIOSIMILAR DRUGS ARE NOT GENERICS.
Zangeneh F, Dolinar R.
Endocr Pract. 2016 Jan;22(1):6-7. doi: 10.4158/EP151135.ED.
Generically speaking.
[No authors listed]
Drug Ther Bull. 2009 Oct;47(10):109. doi: 10.1136/dtb.2009.09.0039.
Branded generics.
Somberg JC.
J Clin Pharmacol. 1993 Sep;33(9):779. doi: 10.1002/j.1552-4604.1993.tb01951.x.
Evaluating the bioequivalence of clopidogrel generic formulations.
Tsoumani ME, Ntalas IV, Goudevenos JA, Tselepis AD.
Curr Med Res Opin. 2015 May;31(5):861-4. doi: 10.1185/03007995.2015.1028912. Epub 2015 Apr 1.
Biosimilar versus generic drugs: same but different?
van de Vooren K, Curto A, Garattini L.
Appl Health Econ Health Policy. 2015 Apr;13(2):125-7. doi: 10.1007/s40258-015-0154-9.
Evergreened drugs or evergreened profits?
Siddalingaiah S, Fugh-Berman A.
J Eval Clin Pract. 2022 Dec;28(6):1119-1126. doi: 10.1111/jep.13695. Epub 2022 May 11.
Understanding generics.
Kircik LH.
J Drugs Dermatol. 2014 Jul;13(7):s75-6.
